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Psycho‐Oncology. 2020;29:49–60.Abstract
Objective: The objective of this study is to evaluate current evidence for the effec-
tiveness of distance‐based interventions to support smoking cessation (SC) or alcohol
moderation (AM) among cancer survivors. Secondary, differences in effectiveness are
explored regarding multibehaviour interventions versus single‐behaviour interven-
tions targeting SC or AM only.
Methods: A systematic search of PubMed, PsycINFO, Web of Science, EMBASE,
CINAHL, and Cochrane Central Register of Controlled Trials was conducted.
Intervention studies with and without control groups and randomized controlled trials
were included. Random effects meta‐analyses were conducted for the main
outcomes: SC and AM rates at the follow‐up closest to 6 months. Using subgroup
analyses and meta‐regression, effectiveness of single‐behaviour versus
multibehaviour interventions was evaluated.
Results: A total of 17 studies with 3796 participants; nine studies on SC only, eight
studies on multibehaviour interventions including an SC or AM module, and no
studies on AM only were included. All studies had at least some concerns
regarding bias. Distance‐based SC interventions led to higher cessation rates than
control conditions (10 studies, odds ratio [OR] = 1.56; 95% CI, 1.13‐2.15, P = .007).
Single‐behaviour SC interventions reduced smoking rates compared with baseline
(risk difference [RD] = 0.29; 95% CI, 0.19‐0.39, P < .0001), but multibehaviour
interventions did not (RD = 0.13; 95% CI, −0.05 to 0.31, P = 0.15). There was
insufficient evidence that distance‐based multibehaviour interventions reduced
alcohol use compared with controls (three studies, standardized mean difference
[SMD] = 0.12; 95% CI, −0.08 to 0.31, P = .24).
Conclusions: Distance‐based SC interventions are effective in supporting SC
among cancer survivors. Single‐behaviour SC interventions appear more effective
than multibehaviour interventions. No evidence was found for the effectiveness of
distance‐based AM interventions for cancer survivors.- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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cessation1 | BACKGROUND
Alcohol and tobacco are classified as group I carcinogens,1,2 and their
use is one of the largest preventable risk factors for cancer occur-
rence.3 Alcohol and tobacco use contribute to cancer recurrence and
second cancers,4-6 cancer mortality,7,8 and iatrogenic effects of treat-
ment.9 Smoking and alcohol use contribute considerably to the total
number of cancer cases.10,11 Attributable cancer deaths in the United
States are estimated at 28.8% and 4.0%, respectively.12,13
Smoking cessation (SC) and alcohol moderation (AM) are
important for cancer survivors.14 This is particularly true for patients
with cancers known to be strongly associated with smoking or
alcohol use (eg, lung, breast, colorectal, head, and neck cancer).3
Nonetheless, rates of smoking and excessive alcohol use among
cancer survivors are high.15-17 One study among 50 000 US cancer
survivors found that 16.1% smoked and 5.1% were heavy drinkers,
rates similar to those for people without cancer (18.6% and 6.0%,
respectively).18
Several psychological interventions to reduce alcohol and
tobacco use among cancer survivors are available. These
interventions are generally provided face to face or via telephone,
and their effectiveness has been described in several reviews. One
meta‐analysis on SC interventions for all cancer survivors19 was
published in 2013, and a second one on SC counselling interventions
for head and neck cancer survivors20 in 2016. A narrative review
without meta‐analysis on both AM and SC interventions for head
and neck cancer survivors21 was published in 2018. Until now, no
meta‐analysis has been published on AM interventions for cancer
survivors.
The two meta‐analyses on SC interventions included randomized
controlled trials (RCTs) and non‐randomized studies. Nayan et al19
reviewed 10 RCTs and three prospective cohort studies and found
no evidence for the effectiveness of SC interventions compared with
control groups after a mean follow‐up time of 5 weeks (odds ratio
[OR] = 1.54; 95% CI, 0.91‐2.64, P = .108) and 6 months (OR =
1.31; 95% CI, 0.931‐1.84, P = .120). However, SC interventions
delivered in the perioperative period were found to be effective
(OR = 2.31; 95% CI, 1.32‐4.07), possibly because the preoperative
period functions as a “teachable moment” associated with increased
motivation to change unhealthy lifestyle behaviours. Klemp et al20
reviewed SC interventions for head and neck cancer patients and
found three RCTs, three cohort studies, and two case studies,
concluding that counselling increased the cessation rate with 26%
(relative risk [RR] = 0.76 favouring experimental condition; 95% CI,
0.59‐0.97, P = .03).
One study21 systematically reviewed RCTs on SC and AM
interventions among head and neck cancer survivors and patientswith oral dysplasia, finding only three eligible RCTs and no RCT
aimed solely at AM. Results on AM interventions among cancer
survivors are clearly scarce, but reviews of studies among the gen-
eral population are available. A systematic review comparing AM‐
guided and AM‐unguided low‐intensity Internet interventions found
that participants used on average 22 g of ethanol less than
controls.22 A systematic review on brief AM interventions delivered
in a primary care setting found similar results (mean difference of
−20 g/wk; 95% CI, −28 to −12).23 Assessment of incorporated
behaviour change techniques (BCTs), theoretical underpinnings,
and modes of delivery contributes to gaining further insight into
factors possibly influencing effectiveness of SC and AM
interventions.24
Health behaviour interventions can focus on changing a single
behaviour25 or multiple health behaviours simultaneously, sometimes
referred to as multiple health behaviour change interventions.26
Theoretically, multiple‐behaviour interventions can have
benefits over single‐behaviour interventions because of greater
real‐world applicability and information provision on effective
treatments for co‐occurring behaviours, eg, alcohol and tobacco
use.27 However, a Cochrane review based on 12 RCTs concludes
that multiple‐behaviour rehabilitation interventions for cancer
survivors might be less effective than single‐behaviour interventions
with regard to maintaining or improving physical and psychosocial
well‐being,28 but this has not yet been evaluated for SC and
AM specifically. In addition, improvement on all targeted behaviours
of a multiple‐behaviour intervention is scarce,29 and cancer survivors
are less likely to choose alcohol as the first behaviour to
change.30 Findings are mixed in non‐cancer survivor populations
receiving intensive substance use treatment for alcohol and
smoking.31-33
The increasing population of cancer survivors34 suggests an
increased need for scalable evidence‐based SC and AM interventions.
Furthermore, self‐management strategies have shown several benefi-
cial effects in cancer survivors, including increase of self‐efficacy.35
Distance‐based interventions (ie, telephone, print, or web based) offer
autonomy and reassurance to cancer survivors36 and may be effective
and/or cost‐effective.37,38 A systematic review and meta‐analysis of
studies testing the effectiveness of distance‐based SC and AM inter-
ventions for cancer survivors, which encourage SC and reduce alcohol
intake, is lacking.
Therefore, in this systematic review and meta‐analysis, we will
address the following questions: (a) Do distance‐based interventions
increase SC rates and/or reduce alcohol use among cancer survivors?
(b) Are single‐behaviour interventions targeting SC or AM more effec-
tive than multibehaviour interventions including SC and/or AM
modules?
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2.1 | Search strategy
A systematic literature search of PubMed, PsycINFO, Web of
Science, EMBASE, CINAHL, and Cochrane Central Register of
Controlled Trials was conducted from inception to December 20,
2017, updated on November 8, 2018. The search string included a
combination of synonyms for smoking, alcohol use, health behav-
iours, intervention, and cancer survivors (Appendix S1). Due to the
expected paucity of literature and to optimally cover the available
evidence, we included both RCTs and intervention studies with
and without a control group. This review was conducted in accor-
dance with the Preferred Reporting Items for Systematic Reviews
and Meta‐Analyses (PRISMA) statement39 and was registered in
the International Prospective Register of Systematic Reviews (PROS-
PERO identifier: CRD42017074567).2.2 | Eligibility criteria
We included English peer‐reviewed publications that evaluated the
effectiveness of distance‐based interventions aiming to reduce alcohol
use and encourage SC or both, targeted cancer survivors, reported rel-
evant outcomes, and were designed as an RCT or non‐randomized
study with or without control group. Interventions should be aimed
at behaviour change of the individual. “Distance based” was opera-
tionalized as an intervention delivered at least 80% remotely and/or
asynchronously, meaning that no more than 20% of total session time
was delivered face to face or, in cases where information on session
time was unavailable, no more than 20% of the total number of ses-
sions. For example, interventions were included containing one‐time
face‐to‐face contact and continuation with several sessions by tele-
phone or other remote‐delivery modes. Cancer survivors are defined
as those ever diagnosed with cancer, irrespective of treatment phase
or life expectancy. Any participant who identifies as a smoker or had
smoked in the past 7 days was considered a smoker. Anyone who
had not smoked in the last 7 days or identifies as a non‐smoker was
considered a non‐smoker. Anyone who drank alcohol in the past week
was considered a drinker.2.3 | Study selection and data extraction procedures
First, two researchers (A.M. and L.L.) independently screened titles
and abstracts for eligibility and then read the full texts of potentially
eligible articles. Disagreements were resolved through consensus
meetings; when necessary, a third author (M.B.) was consulted. Refer-
ence lists of included papers were checked for additional eligible
articles.
Extracted data from each article included title, author, year, country,
participant characteristics, cancer site, study design, relevant outcome
measures, effect sizes (number of smokers, number of non‐smokers,
non‐responders, drinks per d/wk, standard deviation, and P values),follow‐up period, control group, and intervention characteristics. Deliv-
ery mode, guidance level, number of sessions, main intervention target,
theoretical base, control group, relevant outcome measures, and
reported BCTs according to Michie's taxonomy24 were coded by two
researchers (A.M. and L.L.). Study protocols or intervention develop-
ment papers mentioned in the included papers were also checked,
mainly to extract intervention characteristics and to assess risk of bias
(RoB). Authors of the included studies were contacted in case of uncer-
tainty regarding outcome data.
Studies reporting sufficient outcome details were included in the
meta‐analysis. The outcome assessment (closest to) 6 months after
randomization was used in all analyses, as done in a previous similar
review.202.4 | RoB and methodological quality assessment
Risk of bias was assessed at the outcome level using the Cochrane
RoB tool 2.0 (RCTs),40 ROBINS‐I tool41 (non‐randomized studies with
a control group [NR + CG]), and a standardized form for quality assess-
ment of before and after studies without control group from the US
National Heart, Lung and Blood Institute42 (non‐randomized studies
without a control group [NR − CG]). Two authors (A.M. and J.B.) inde-
pendently assessed RoB and reached consensus.2.5 | Statistical methods
Random effects meta‐analysis was conducted for SC and AM inter-
ventions separately. A pooled effect size was calculated between
groups (intervention vs control, primary analysis) and within groups
(before vs after intervention) where possible. For AM, mean number
of drinks per week at baseline and follow‐up was used to calculate
Hedges' g (intervention vs control: between‐group change) or SMC
(standardized mean change, before vs after intervention: within‐group
change). For the AM within‐group comparison, SMC was calculated
with a conventionally assumed pretest/post‐test correlation43 of r =
0.70 and following the Morris procedure.44
For SC studies, the numbers of smokers, non‐smokers, and non‐
responders at baseline and follow‐up were extracted, for both
intervention and control groups. Non‐responders were excluded from
the analysis as some studies included non‐smokers at baseline and base-
line smoking status of the non‐responders was not always clear; thus,
the “missing‐is‐smoking” procedure could not be applied. Because this
procedure is more common in SC research, sensitivity analyses applying
this procedure to appropriate studies, resulting in intention‐to‐treat
analyses, were carried out. For the SC within‐group meta‐analyses, risk
differences (RDs) were reported; ORs were used as effect sizes when
comparing intervention to control groups.
Heterogeneity was quantified in both AM and SC using the I2
statistic and tested for significance using the Q test. Using subgroup
analyses and random effects meta‐regression analysis with study as
the random component, a possible source of heterogeneity, ie, dimen-
sionality, was explored.45 Publication bias was intended to be visually
MUJCIC ET AL.52evaluated by means of funnel plots, Egger's regression test, and the
rank sum correlation test.
A two‐sided P value of less than.05 was considered statistically
significant. All statistical analyses were conducted in R software (ver-
sion 3.5.1), with meta‐analyses performed using the metafor
package.463 | RESULTS
3.1 | Study selection
The initial search strategy identified 6652 records, which included
2372 duplicates as identified by software programs Covidence47
and Mendeley (version 1.19.2).48 After abstract screening of the
remaining 4280 records, 242 records were reviewed in full text.
One additional study was identified through reference list searching
of included studies. This yielded 17 studies for inclusion in
the systematic review, of which 14 could be used for meta‐analysis
(Figure 1); one study did not provide sufficient outcome data for
meta‐analysis,49 and two were secondary studies of the same trial,50
describing an additional follow‐up assessment51 and process
evaluation.523.2 | Study characteristics
Most studies (76%, 13/17) were published between 2010 and 2018,
the remainder being published between 2005 and 2009. Studies were
carried out in the United States (76%, 13/17), two in Australia, one in
The Netherlands, and one in the United Kingdom. Most studies were
RCTs (71%, 12/17); four were NR − CG (23%), and one was NR +
CG (6%). Two articles described secondary studies51,52 of an already
included trial50; as these reported the same sample of participants,
they were excluded from the quantitative analyses. The remaining
15 studies included a total of 3796 participants, with a mean sample
size of 253.1 (SD = 236.5) and a mean participant age of 52.8 (SD =
14.3) years; 58.6% were women (see Table 1).
3.3 | Intervention characteristics
Fifteen unique interventions are described (Table S2). Most interven-
tions were delivered by telephone (12/15),50,53,54,58-60,63,64,66-69 often
supplemented with printed materials (6/12)50,54,58-60,67 and explicit
encouragement of pharmacotherapy or nicotine replacement therapy
(NRT) (8/12)50,53,54,63-67; three interventions involved face‐to‐face
contacts in addition to remote delivery.54,65,66 The remaining interven-
tions were unguided web based (3/15),25,26,49 with one explicitly
encouraging use of pharmacotherapy or NRT.25 Half of interventions
targeted smoking only (7/15)25,50,53,63-66; one multiple‐behaviourFIGURE 1 Study selection process
TABLE 1 Study characteristics
Reference Country
Sample
Size, n
Age
(Mean Years)
Gender
(% Female)
Study
Design Control Group
Relevant
Outcome
Measures Cancer Site
Amato et al53 USA 250 61.9 59.8 NR − CG ‐ SC: 7 Thoracic
Berg et al49 USA 24 23.38 70.8 NR − CG ‐ AM: 1, SC: 4 Lymphoma,
leukaemia,
osteosarcoma,
thyroid,
glioblastoma,
Wilm's tumour
Duffy et al54 USA 184 57 16 RCT Enhanced care as usual: face‐
to‐face assessment and
brief counselling, handout
with resources, referrals
AM: 9, SC: 7 Head and neck
Emmons et al50 USA 796 31 47 RCT Printed information brochure SC: 7, 8 Leukaemia, CNS,
lymphoma,
kidney,
neuroblastoma,
soft tissue
sarcoma, bone
Emmons et al51,a USA 565 31 51.0 RCT Printed information brochure SC: 7, 8, 5 Leukaemia, CNS,
lymphoma,
kidney,
neuroblastoma,
soft tissue
sarcoma, bone
Emmons et al25
+protocol55
USA 374 32 49.7 RCT Active: printed, tailored, and
targeted self‐help manuals,
NRT/pharmacotherapy
SC: 5, 7, 8 Leukaemia, CNS,
lymphoma,
bone, other
Fazzino et al56
+protocol57
USA 37 57.8 100 RCT Active: biweekly information
brochures
AM: 3 Breast
Grimmett et al58 UK 29 65 62 NR − CG ‐ AM: 2 Colorectal
Hawkes et al59 Australia 20 66.0 (median) 50 NR − CG ‐ AM: 1, SC: 4 Colorectal
Hawkes et al60
+protocol61
Australia 410 66.4 46.1 RCT Printed information brochure AM: 2, 3 SC:
7
Colorectal
Kanera et al26
+protocol62
The Netherlands 462 55.9 79.9 RCT Waitlist SC: 7 Breast (71%),
other
Klesges et al63 USA 519 ‐ 45.1 RCT Active: participant‐initiated
telephone counselling and
2 weeks of NRT/
pharmacotherapy
(compared with caregiver
initiated and 4 wk of NRT)
SC: 6, 7, 8 NR
Klesges et al64 USA 427 ‐ 67.0 RCT Active: participant‐initiated
telephone counselling and
2 weeks of NRT/
pharmacotherapy
(compared with caregiver
initiated and 4 wk of NRT)
SC: 6, 7 NR
Ostroff et al65 USA 185 55.9 53 RCT Active: counselling and NRT SC: 5, 7 Thoracic, head
and neck,
breast,
gynaecological,
urology, other
Park et al52,b USA 398 30.9 47.5 RCT Printed information and
manual on cessation
SC: 5, 7, 8 Leukaemia, CNS,
lymphoma,
(Continues)
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TABLE 1 (Continued)
Reference Country
Sample
Size, n
Age
(Mean Years)
Gender
(% Female)
Study
Design Control Group
Relevant
Outcome
Measures Cancer Site
kidney,
neuroblastoma,
soft tissue
sarcoma, bone
Park et al66 USA 49 57.7 59.2 NR + CG
study
Care as usual: not further
specified
SC: 6, 7 Thoracic
Pollak et al67 USA 30 56.8 73 RCT
(pilot)
Waitlist SC: 5, 6, 7 Breast 33%, lung
20%, colon
10%, other
Note. 1 = days of drinking; 2 = number of drinks or grams of alcohol per week; 3 = number of drinks or grams of alcohol per day; 4 = days of smoking; 5 =
cigarettes per day; 6 = smoking abstinence/smoking status biochemically verified; 7 = smoking abstinence/smoking status self‐report; 8 = quit attempts; 9 =
AUDIT.
Abbreviations: AM, alcohol moderation; CNS, central nervous system; NR, not reported; NR + CG, non‐randomized with control group; NR − CG, non‐ran-
domized without control group; NRT, nicotine replacement therapy; RCT, randomized controlled trial; SC, smoking cessation.
aDescribes additional follow‐up to Emmons et al.50
bSecondary study on intervention participants of Emmons et al.50
MUJCIC ET AL.54intervention targeted smoking, alcohol use, and depression,54 and one
multiple‐behaviour intervention targeted smoking and pain
management.67 None of the interventions targeted alcohol use solely.
The remaining multiple‐behaviour interventions targeted general life-
style and health‐related behaviours including diet and physical activity
(6/15), of which four included an SC module26,49,59,60 and six an AM
module.26,49,58-60,68 Reported theoretical/therapeutic underpinnings
varied and included motivational interviewing (MI) (5/15),50,60,65-67
cognitive behavioural therapy (CBT) (4/15),54,63,64,67 and problem‐
solving therapy (3/15).26,60,683.4 | RoB within studies
At least some concerns regarding RoB were identified for all RCTs
(Tables S3). RoB in selection of the reported result was high or with
some concerns in all but one study,60 as these studies did not refer
to a published protocol paper with prespecified analyses. Bias due to
missing outcome data was low in six studies,25,26,50,54,60,65 indicating
robustness of the outcomes against the impact of missing data. As
the randomization process was often well described and (lack of) base-
line imbalances well reported, no studies were at high RoB. Most stud-
ies elicited some concerns about bias due to deviations from intended
interventions or bias in measurement of the outcomes (because
blinding was not reported or absent). For detailed RoB and quality
assessments of all studies, including NR − CG and NR + CG studies,
see Table S3.3.5 | SC and AM outcome measures
Smoking status or abstinence was assessed in most SC studies, except
for Berg et al49 who reported number of smoking days instead of
smoking status. Hawkes et al59 reported smoking status based onsmoking days, cigarettes per day, and age of commencing and quitting
smoking. Self‐reported smoking status was available in the 11 remain-
ing SC studies, operationalized as 7‐day point‐prevalence absti-
nence,26,63,64,66,67,69,70 30‐day point‐prevalence abstinence,25 24‐
hour abstinence,53 or unspecified duration of quit status.54,60 In five
studies, self‐reported abstinence was verified with cotinine assess-
ments.63,64,66,67 Duration of follow‐up differed from end of treatment
(6 wk) to a maximum of 18 months. For SC meta‐analyses, only one
study could not be included as it reported number of smoking days
but not number of smokers.49
Assessment of alcohol use varied. Two studies measured mean
alcohol use in grams per day,56,60 the others measured drinking days
in the past month,49 alcohol units per week,58 or AUDIT scores, a
standard screening measure for alcohol problems.54 Hawkes et al59
classified participants in high‐risk, low‐risk, and non‐drinker catego-
ries. For AM meta‐analyses, two studies54,59 could not be included,
because no SMC could be calculated from the reported AUDIT scores
and drinking days. See Table S4 for an overview of study outcomes.3.6 | Effects on smoking
3.6.1 | Within groups
On the basis of the within‐group data (preintervention and
postintervention) from 12 studies,25,26,50,53,54,59,60,63-67 a pooled RD
of 0.23 (95% CI, 0.13‐0.33, P < .0001) was found in favour of
distance‐based interventions (Figure 2). Mean follow‐up time was
4.7 months (range 1.5‐15, SD = 3.9). A high level of heterogeneity
was observed (I2 = 96.07%, Q = 207.9, P < .0001). Results were similar
when including RCTs only25,26,50,54,60,63,64,67,69 (RD = 0.23; 95% CI,
0.12‐0.34, P < .0001; I2 = 96.63%, Q = 186.6, P < .0001).
Subgroup analyses were carried out on single‐behaviour–focussed
interventions and multiple‐behaviour interventions. Single‐behaviour
FIGURE 2 Forest plots of intervention effects. A, Intervention effect within groups: before and after intervention effect on smoking cessation
rate. B, Intervention effect between groups: intervention and control group effect on smoking cessation rate. C, Intervention effect within groups:
before and after intervention effect on alcohol moderation. D, Intervention effect between groups: intervention and control group effect on
alcohol moderation
MUJCIC ET AL. 55interventions25,50,53,63-66 yielded a significant pooled RD of 0.29 (95%
CI, 0.19‐0.39, P < .0001). After one outlier was excluded,25 the pooled
RD was 0.32 (95% CI, 0.23‐0.41, P < .0001), and heterogeneity
between studies was reduced (I2 = 86.42%, Q = 25.9, P < .0001).
Multiple‐behaviour interventions26,54,59,60,67 produced a non‐
significant pooled RD of 0.13, and heterogeneity remained high
(95% CI, −0.05 to 0.31, P = .15; I2 = 95.39%, Q = 41.9, P < .0001). After
one outlier was excluded,54 the pooled RD was 0.02 (95% CI, −0.01 to
0.05, P = .26; I2 = 0.11%, Q = 2.0, P = .58). A meta‐regression also
pointed towards a larger intervention effect for single‐behaviour com-
pared with multiple‐behaviour interventions but failed to reach signif-
icance (B = 0.17; 95% CI, −0.02 to 0.36, P = .08).
3.6.2 | Between groups
Ten studies included a control group25,26,50,54,60,63-67; nine of which
were RCTs. Overall smoking rates in intervention groups were lower
than in control groups (OR = 1.56; 95% CI, 1.13‐2.15, P = .007; I2 =
53.59%, Q = 19.2, P = .02). Mean follow‐up time was 5.3 months
(SD = 4.0). When excluding one non‐randomized study,66 the result
did not change notably (OR = 1.50; 95% CI, 1.08‐2.07, P = .01; I2 =
55.18%, Q = 17.5, P = .03).
Subgroup analyses showed similar ORs for single‐behaviour inter-
vention (OR = 1.56; 95% CI, 0.97‐2.50, P = .06; I2 = 73.30%, Q =
17.9, P < .01)25,50,63,64,66,69 and multiple‐behaviour intervention(OR = 1.47; 95% CI, 0.97‐2.24, P = .07; I2 = 0, Q = 1.1, P =
.77).26,54,60,67 A meta‐regression showed that no heterogeneity was
explained by dimensionality (B = 0.04; 95% CI, −0.72 to 0.80, P =
.91). No notable differences from the main within‐group and
between‐group analyses were found in sensitivity analyses applying
the “missing = smoking” procedure to appropriate
studies.25,50,63,64,66,67,693.7 | Effects on alcohol use
3.7.1 | Within groups
Pooled SMC was not significant at.27 (95% CI, −0.12 to 0.66, P = .17;
I2 = 87.15%, Q = 13.5, P < .01), based on within‐group (preintervention
and postintervention) analysis of four included studies.49,56,58,60 All
included AM interventions were multibehaviour focussed. Mean
follow‐up period was 7.5 months (SD = 7.1).3.7.2 | Between groups
Three studies included a control group.54,56,60 The pooled effect esti-
mate was SMD = 0.12 (95% CI, −0.08 to 0.31, P = .24; I2 = 0%, Q =
0.05, P = .98) (Figure 2). Mean follow‐up period was 10 months (SD
= 6.9). All included AM interventions were multibehaviour focussed
MUJCIC ET AL.563.8 | Risk of publication bias across studies
The number of studies involved in the between‐group comparison
meta‐analyses was low for SC (n = 10) and especially for AM (n = 3).
The initial funnel plot for SC does not show noteworthy deviations
(see Figure S5), and Egger's test (P = .90) and the rank correlation test
(P = 1.0) indicate that there is no statistical reason to assume a
publication bias. No notable differences occur when only including
RCTs (n = 9). Publication bias for AM studies was not assessed as
there were inadequate numbers of included trials to properly assess
a funnel plot.4 | DISCUSSION
On the basis of the synthesis of the evidence collected in our review,
we conclude that distance‐based SC interventions are effective in
reducing tobacco use among cancer survivors. For AM, we found
insufficient evidence that distance‐based interventions are
effective for cancer survivors. We also found evidence that single‐
behaviour–focussed SC interventions appear to be more effective
than multiple‐behaviour interventions based on within‐group
preintervention versus postintervention outcomes for SC. This differ-
ence between single‐ and multiple‐behaviour interventions was not
found in the meta‐regression or between‐group analyses, which are
at lowest RoB. As we found no single‐behaviour AM interventions,
we could not assess a possible difference in effectiveness between
single‐behaviour and multiple‐behaviour AM interventions.
The current findings match and extend the findings of earlier meta‐
analyses on SC interventions for cancer survivors.19,20 SC interven-
tions are more effective than control interventions, although one
review only found an effect for interventions around the perioperative
period71; this discrepancy might be explained by the inclusion of more
recent studies in the current meta‐analysis. We found no effect on
AM, possibly due to the low number of reported AM studies for can-
cer survivors. Nonetheless, this review identified more studies on
interventions targeting AM in cancer survivors than a previous review
by Shingler et al,21 which only included three RCTs. Previous reviews
on AM interventions in the general population have been based on
single‐behaviour interventions aimed solely at AM,22,23 while our
review only included multiple‐behaviour interventions. This could also
explain the lack of evidence regarding the effectiveness of distance‐
based AM interventions.
Our within‐group findings, suggesting that multiple‐behaviour
interventions are less effective than single‐behaviour–focussed inter-
ventions, are based on subgroup analyses of single‐behaviour and
multibehaviour interventions comparing before and after SC rates.
The meta‐regression on before and after SC rates pointed in the same
direction, although it failed to reach significance (B = 0.17; 95% CI,
−0.02 to 0.36, P = .08). Neither the subgroup analyses nor the meta‐
regression on between‐group differences showed a difference in
effectiveness for single‐behaviour and multibehaviour interventions.
These findings match evidence from a Cochrane review onmultidimensional rehabilitation programmes for cancer survivors.28
Pollak et al67 and Duffy et al54 found a larger effect (RD = 0.22;
95% CI, −0.07 to 0.50, and RD = 0.46; 95% CI, 0.32‐0.59, respectively)
than the other multibehaviour studies but focussed on a limited num-
ber of behavioural targets (SC and pain management or SC, AM, and
depression reduction), whereas the other multiple‐behaviour interven-
tions targeted lifestyle in a much broader sense.
A recent systematic review of alcohol interventions in older people
based on individual patient data reported marked control group
effects72 and might partly explain the differing results in within‐ and
between‐group analyses for single‐behaviour and multibehaviour SC
interventions. Three studies that included a face‐to‐face compo-
nent54,66,69 show the greatest effect in the within‐group analyses
but not in the between‐group analyses (see Figure 2), where this
effect might have been moderated by the control group, diminishing
the contrast.
The current review used a robust search strategy and is reported
according to PRISMA guidelines. In order to optimally cover the avail-
able evidence on distance‐based and scalable SC and AM interven-
tions for cancer survivors, this review included studies on all cancer
types, non‐randomized studies (NR + CG and NR − CG), and
multiple‐behaviour studies with an AM or SC module. Results for
RCTs are described separately when there were more than two RCTs
to be pooled.5 | CONCLUSIONS
Distance‐based SC interventions can be effective in addressing SC in
cancer survivors, although the amount and the quality of the evidence
are suboptimal. Factors upon which effectiveness depends need to be
further investigated. There are indications that single‐behaviour–
focussed SC interventions are more effective than multibehaviour
interventions. We did not find sufficient evidence to draw firm conclu-
sions on the effectiveness of distance‐based AM interventions. More
high quality studies are needed.5.1 | Study limitations
The current findings should be considered in light of the study limita-
tions. The number of studies included in the meta‐analyses was low,
particularly for AM, and statistical heterogeneity in both SC and AM
studies was relatively high. This heterogeneity can be due to several
factors: heterogeneity in modes of delivery, effect sizes, follow‐up
periods, and study designs. Use of RDs can also account for the very
high heterogeneity in the within‐group SC comparison, as these are
absolute outcomes.45 If included, control groups also varied
considerably; several were handed printed information materials,
while others were provided with active counselling and medication.
In one study, control groups were waitlisted,26 and in another, the
control group condition was not further specified.66 Bias could have
been introduced as no information was available on correlation
between preintervention and postintervention measures, and
MUJCIC ET AL. 57therefore, a conventional pretest‐post‐test correlation of 0.70 was
assumed. There was considerable loss of data in several studies due
to non‐response (Table S4), but applying the “missing = smoking” pro-
cedure for appropriate studies (not including non‐smokers at baseline)
did not yield different conclusions. Furthermore, for all outcome mea-
sures, there were at least some concerns about the RoB. Subgroup
analyses covering cancer site, mode of delivery, or other potential
moderators were not possible because of the low number of studies.
Identified BCTs in the current systematic review (Table S2) are limited
as intervention information was only extracted from published inter-
vention descriptions.5.2 | Clinical implications
The current review demonstrated that distance‐based SC interven-
tions are more effective in encouraging SC than controls. SC interven-
tions differed in number of sessions, theoretical and therapeutic
underpinnings, and level of guidance, suggesting that a diverse set of
interventions can be effective and that tailoring the intervention
according to the patient's wishes or caregiver's possibilities could be
a positive feature. Considering the demonstrated possible superior
effect of single‐behaviour over multiple‐behaviour interventions for
SC, there is opportunity for further developing distance‐based
single‐behaviour AM interventions for cancer survivors. Direct com-
parisons between multiple‐behaviour and single‐behaviour interven-
tions in randomized trials are needed to be conclusive. Future work
should also focus on conducting and reporting SC and AM trials
among cancer survivors according to Consolidated Standards of
Reporting Trials (CONSORT) statement guidelines in order to limit
RoB and further explore possible moderators.
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